SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-070743
Filing Date
2023-12-15
Accepted
2023-12-15 16:15:08
Documents
12
Period of Report
2023-12-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20231213.htm   iXBRL 8-K 64843
  Complete submission text file 0000950170-23-070743.txt   185423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20231213.xsd EX-101.SCH 2389
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20231213_pre.xml EX-101.PRE 10917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20231213_lab.xml EX-101.LAB 14388
6 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20231213_htm.xml XML 4690
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 231490483
SIC: 2834 Pharmaceutical Preparations